MULVIHILL MARK J.,STEINIG ARNO G.,CREW ANDREW PHILIP,JIN MEIZHONG,KLEINBERG ANDREW,LI AN-HU,WANG JING,WANG J
申请号：
PL11721678
公开号：
PL2569314T3
申请日:
2011.05.16
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
